Incidence of sudden cardiac death in congestive heart failure: Chagas disease versus systemic arterial hypertension

2014 ◽  
Vol 175 (1) ◽  
pp. 175-176 ◽  
Author(s):  
Henrique Horta Veloso
1998 ◽  
Vol 93 (0) ◽  
pp. s101-s108 ◽  
Author(s):  
R. Dietz ◽  
R. von Harsdorf ◽  
M. Gross ◽  
J. Krämer ◽  
D. Gulba ◽  
...  

Heart Rhythm ◽  
2005 ◽  
Vol 2 (5) ◽  
pp. S39 ◽  
Author(s):  
Gust H. Bardy ◽  
Kerry L. Lee ◽  
John P. Boehmer ◽  
Daniel B. Mark ◽  
Jeanne E. Poole ◽  
...  

ESC CardioMed ◽  
2018 ◽  
pp. 2313-2316
Author(s):  
Borislav Dinov

The current understanding recognizes dilated cardiomyopathy as a condition defined by cardiac enlargement that manifests clinically with symptoms of congestive heart failure. However, sudden cardiac death (SCD) can be the first clinical manifestation of the disease as well, although the main cause of death remains advanced heart failure. In patients with dilated cardiomyopathy, implantation of an implantable cardioverter defibrillator (ICD) reduced the mortality rate by approximately 30%, indicating that ventricular tachycardia and ventricular fibrillation are important causes of death. However, severe bradycardia or pulseless electrical activity can contribute as a cause of SCD as well. Since ICDs are highly efficacious in the prevention of SCD, identifying patients at highest risk of SCD is crucial for saving life, reducing associated complications, and reducing the burden of costs. However, registry data showed that the majority of sudden deaths occur in patients who do not fulfil the criteria for primary prevention with an ICD.


2013 ◽  
Vol 168 (3) ◽  
pp. 2990-2991 ◽  
Author(s):  
Reinaldo B. Bestetti ◽  
Ana Paula Otaviano ◽  
João Paulo Fantini ◽  
Augusto Cardinalli-Neto ◽  
Marcelo A. Nakazone ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document